"A new microneedle patch being developed by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) could make it easier to vaccinate people against measles and other vaccine-preventable diseases.
- Inform parents or guardians of the potential benefits and risks of immunization with MENHIBRIX, and of the importance of completing the immunization series.
- Inform parents or guardians about the potential for adverse reactions that have been temporally associated with administration of MENHIBRIX or other vaccines containing similar components.
- Instruct parents or guardians to report any adverse events to their healthcare provider.
- Give parents or guardians the Vaccine Information Statements, which are required by the National Childhood Vaccine Injury Act of 1986 to be given prior to immunization. These materials are available free of charge at the Centers for Disease Control and Prevention (CDC) website (www.cdc.gov/vaccines).
Last reviewed on RxList: 10/22/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional MenHibrix Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.